The heightened trade war with China hands US stocks their biggest one-day drop in months, Uber shares lose more than a tenth of their value in the ride-hailing app’s second day of trading and a California court orders Bayer to pay more than $2bn in damages to a pair of cancer patients who claimed that their non-Hodgkin’s lymphoma was caused by the German group’s weedkiller, RoundUp. Plus, the FT’s pharmaceutical and biotech reporter, Hannah Kuchler, explains why a lawsuit backed by 44 US states alleges that some generic drugmakers, including Teva and Pfizer, have been fixing prices of more than 100 drugs.

A transcript for this podcast is currently unavailable, view our accessibility guide.

Get alerts on FT News Briefing when a new story is published

Copyright The Financial Times Limited 2019. All rights reserved.
Reuse this content (opens in new window)

Comments have not been enabled for this podcast.

Follow the topics in this podcast